Add BrightSurf on Google Email

Children's National Hospital


First-of-its-kind cell therapy clinical trial led by Children’s National shows promising long-term survival in children with aggressive brain tumors

A Phase I trial evaluated a novel multi-targeted T-cell therapy for children with deadly brain tumors, offering early evidence that the patient's own immune cells can reach and fight tumors while producing fewer severe side effects. The study suggests a safer and more effective approach for pediatric brain cancers.

SourceChildren's National Hospital·JournalNature Medicine·DateJun 30, 2026

Novel AI platform matches cardiologists in detecting rheumatic heart disease

A new AI platform matches cardiologists in detecting rheumatic heart disease, demonstrating its potential to prevent hundreds of thousands of unnecessary deaths worldwide annually. The AI algorithm identified mitral regurgitation in up to 90% of children with RHD, making it a promising tool for early detection and treatment.

SourceChildren's National Hospital·JournalJournal of the American Heart Association·DateJan 16, 2024

Earlier detection of cardiometabolic risk factors for kids may be possible through next generation biomarkers

The American Heart Association statement proposes next-generation biomarkers for earlier detection of cardiometabolic risk factors in children, which can be influenced by heart-healthy nutrition and lifestyle factors. This could lead to better prevention and intervention strategies for obesity, diabetes, and heart disease.

SourceChildren's National Hospital·JournalCirculation·DateOct 31, 2023

Improvements in social, educational and economic-related characteristics of communities may reduce rates of early childhood asthma

Researchers found that neighborhoods with better socioeconomic and educational opportunities had lower rates of asthma-related emergency department visits among children under five years old. This suggests that improving social determinants of health in areas with high asthma morbidity may help reduce childhood asthma rates.

SourceChildren's National Hospital·JournalJournal of Allergy and Clinical Immunology·DateOct 23, 2023

Researchers identify unique biomarker patterns identifying MIS-C and severe COVID in children

Researchers have identified specific biomarker patterns in blood samples that are unique to severe COVID-19 infection and Multisystem Inflammatory Syndrome in Children (MIS-C) in children. These findings may lead to the development of diagnostic tests to predict severe disease and distinguish MIS-C from other conditions.

SourceChildren's National Hospital·JournalCell Reports Medicine·DateApr 21, 2023

What we do and don’t know about the many ways COVID-19 can impact pregnant women and their babies

The COVID-19 pandemic poses significant risks to pregnant women and their newborns, particularly due to viral-induced inflammation in the placenta. Studies have linked SARS-CoV-2 infection to adverse pregnancy outcomes, including stillbirth and severe neonatal illness, which may vary with specific circulating variants.

SourceChildren's National Hospital·JournalThe Journal of Infectious Diseases·DateJan 13, 2022

Personalized T cell immunotherapy for pediatric brain tumors is one step closer to becoming a reality

Researchers at Children's National Hospital have successfully developed a personalized T cell immunotherapy that targets and kills unique proteins in individual tumor cells. This approach, combining genetic sequencing and protein identification, offers a promising treatment option for children with hard-to-treat brain tumors.

SourceChildren's National Hospital·JournalNature Communications·DateNov 18, 2021

Penicillin slows devastating impacts of rheumatic heart disease in children from Uganda

A large-scale trial found that penicillin can prevent progression of latent rheumatic heart disease in Ugandan children. The study enrolled 818 children and showed that early detection coupled with prophylactic treatment significantly reduced worsened heart conditions, offering hope for addressing this neglected disease.

SourceChildren's National Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 13, 2021

Second wave of kids with MIS-C had more severe illness than first wave, according to new Children’s National Hospital study

A new prospective cohort study of 106 patients at Children’s National Hospital found that the second wave of kids with multi-system inflammatory syndrome in children (MIS-C) had more severe illness compared to the first wave. Despite this, both cohorts had similarities in cardiac outcomes and length of stay.

SourceChildren's National Hospital·JournalThe Pediatric Infectious Disease Journal·DateNov 10, 2021

Pediatricians and public health officials should present a united front against controversial state masking bans for schools

Pediatricians and public health officials should present a united front against controversial state masking bans for schools, as these policies contradict evidence-based recommendations. The Delta variant overwhelmed pediatric emergency rooms and hospitals, highlighting the need for effective mitigation strategies.

SourceChildren's National Hospital·JournalPEDIATRICS·DateOct 20, 2021

T cell therapy alone or combined with cancer drug nivolumab is safe and persistent in attacking Hodgkin's lymphoma cells

A new study suggests that T cell therapy alone or combined with cancer drug nivolumab is safe and persistent in attacking Hodgkin's lymphoma cells. The treatment showed promising results in patients with relapsed or refractory HL, offering a potential option for those who do not respond to checkpoint inhibitors.

SourceChildren's National Hospital·JournalBlood Advances·DateSep 8, 2021

COVID-linked multi-system inflammatory syndrome in children diagnosed more in Black and Latino child

A new observational study found that Black and Latino children were significantly affected by COVID-linked multi-system inflammatory syndrome, with cardiac complications more common in critically ill patients. The study also identified distinct cytokine signatures and viral sequencing patterns, shedding light on the disease's demograph...

SourceChildren's National Hospital·JournalThe Journal of Pediatrics·DateJun 25, 2021

Immunocompromised pediatric patients showed T-cell activity and humoral immunity against SARS-CoV-2

A new study found that immunocompromised pediatric patients showed significant T-cell activity and humoral immunity against SARS-CoV-2. The research suggests that vaccination may still be beneficial for this population, particularly those with antibody deficiency disorders. Further studies are needed to confirm these findings.

SourceChildren's National Hospital·JournalJournal of Clinical Immunology·DateMay 13, 2021